Merck known as MSD outside of the United States and Canada, announced that new clinical and outcomes research data will be presented at the American College of Cardiology’s… read more.
When Emily Rosenfeld was doing a fellowship in maternal-fetal medicine at Rutgers Robert Wood Johnson Medical School (RWJMS), she noticed that many patients were returning to the hospital for hypertension…. read more.
Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalisation if they… read more.
Merck known as MSD outside of the United States and Canada, announced that new clinical and outcomes research data will be presented at the American College of Cardiology’s… read more.
Genentech, a member of the Roche Group announced that the FDA has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke (AIS)… read more.
Social media can be a noisy place, more often associated with online misinformation than with supporting public health. However, researchers in Japan have found a way to use… read more.
Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study involving the University of Surrey. In a… read more.
Women with gynecological disorders such as endometriosis or heavy or irregular periods could be at an elevated risk of heart disease and cerebrovascular disease, researchers report. The findings… read more.
One in five older adults gets an infection up to six months after heart surgery — with women far more likely to develop one, according to studies led… read more.
Certain hormonal contraceptives are associated with a higher stroke and heart attack risk, finds a large study from Denmark in The BMJ today that draws on prescription records to give… read more.
In patients with ACS (acute coronary syndrome) who have undergone DES (drug-eluting stent) implantation, de-escalating DAPT (dual antiplatelet therapy) to ticagrelor monotherapy resulted in a lower risk for… read more.
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
